Do inhaled anticholinergics increase the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease?

Daniel Prieto Alhambra, Mauro Don, Alejandro Galán Aisa, Diego Castillo, Carlos Martín Cantera

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)315
JournalFMC Formacion Medica Continuada en Atencion Primaria
Publication statusPublished - 1 Jan 2009

Cite this